Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Schoemaker Kathleen K
Relationship:   10% Owner
City:   Princeton
State:   NJ
   
Insider Summary:
  
   
Companies Owned :   24    
Direct Shares   8,715,548    

Indirect Shares

   3,038,103      
Direct Value   $235,240,146    

Indirect Value

   $11,280,270      
Total Shares   11,753,651      
Total Value   $246,520,416      


Volcano Corp $0 Cadence Pharmaceuticals Inc $0 Orexigen Therapeutics, Inc. $48 Alimera Sciences Inc $1,095,234 Clovis Oncology, Inc. $661 Glaukos Corp $234,144,203 Volcano Corp $0 Cadence Pharmaceuticals Inc $0 Orexigen Therapeutics, Inc. $48 Alimera Sciences Inc $1,095,234 Clovis Oncology, Inc. $661 Glaukos Corp $234,144,203
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Senomyx Inc SNMX 10% Owner 0 2004-06-25 19,603    Premium*  
            Nuvasive Inc NUVA 10% Owner 0 2004-05-18 31,204    Premium*  
            Santarus Inc SNTS 10% Owner 2004-04-06 0 2004-04-06 64,471    Premium*  
            Somaxon Pharmaceuticals, Inc. SOMX 10% Owner 0 2006-12-21 19,379    Premium*  
            Vanda Pharmaceuticals Inc. VNDA 10% Owner 2006-04-18 0 2006-12-12 21,068    Premium*  
            Northstar Neuroscience Inc NSTR 10% Owner 0 2006-05-10 37,586    Premium*  
            Paratek Pharmaceuticals Inc PRTK 10% Owner 0 2009-01-30 67,875    Premium*  
            Volcano Corp VOLC 10% Owner 2008-04-24 29,887 2008-07-16 62,513    Premium*  
            Cadence Pharmaceuticals Inc CADX 10% Owner 2014-02-12 2,972,678 2014-03-19 0    Premium*  
            Orexigen Therapeutics, Inc. OREX 10% Owner 2007-11-27 9,058 2011-12-22 50,643    Premium*  
            Alimera Sciences Inc ALIM 10% Owner 2014-01-16 3,590,931 2011-06-02 40,790    Premium*  
            Achillion Pharmaceuticals Inc ACHN 10% Owner 0 2013-01-18 244,057    Premium*  
            Zogenix, Inc. ZGNX 10% Owner 2010-11-29 0 2011-09-16 169,251    Premium*  
            Clovis Oncology, Inc. CLVS 10% Owner 2013-06-04 44,034 2011-11-21 51,013    Premium*  
            Durata Therapeutics, Inc. DRTX 10% Owner 0 2012-07-24 22,306    Premium*  
            Esperion Therapeutics, Inc. ESPR 10% Owner 0 2013-07-01 35,253    Premium*  
            Ocera Therapeutics Inc OCRX 10% Owner 2013-07-15 0 2013-07-15 1,920,730    Premium*  
            Tobira Therapeutics Inc TBRA 10% Owner 0 2013-08-27 32,091    Premium*  
            Evoke Pharma Inc EVOK 10% Owner 0 2013-09-30 24,256    Premium*  
            Veracyte, Inc. VCYT 10% Owner 2013-11-04 0 2013-11-04 22,730    Premium*  
            Tandem Diabetes Care Inc TNDM 10% Owner 2013-11-19 0 2013-11-19 54,390    Premium*  
            Dicerna Pharmaceuticals Inc DRNA 10% Owner 2014-02-04 0 2014-02-04 13,004    Premium*  
            Achaogen Inc AKAO 10% Owner 2014-03-17 0 2014-03-17 33,890    Premium*  
            Glaukos Corp GKOS 10% Owner 2015-06-30 2,068,960 2015-06-30 0    Premium*  
* Premium Members only  

Records found :    282         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 8 of 12
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ALIM Alimera Sciences Inc 10% Owner   –       –       •   2013-06-11 4 AS $5.00 $26,685 D/D (5,337) 4,080,194 0 -
ALIM Alimera Sciences Inc 10% Owner   –       –       •   2013-06-14 4 AS $5.03 $2,138 D/D (425) 39,823 0 -
ALIM Alimera Sciences Inc 10% Owner   –       –       •   2013-06-14 4 AS $5.03 $195,652 D/D (38,897) 4,041,297 0 -
ALIM Alimera Sciences Inc 10% Owner   –       –       •   2013-06-17 4 AS $5.40 $5,179 D/D (959) 38,864 0 -
ALIM Alimera Sciences Inc 10% Owner   –       –       •   2013-06-17 4 AS $5.40 $474,185 D/D (87,812) 3,953,485 0 -
ALIM Alimera Sciences Inc 10% Owner   –       –       •   2013-06-18 4 AS $5.40 $1,939 D/D (359) 38,505 0 -
ALIM Alimera Sciences Inc 10% Owner   –       –       •   2013-06-18 4 AS $5.40 $177,417 D/D (32,855) 3,920,630 0 -
ALIM Alimera Sciences Inc 10% Owner   –       –       •   2013-06-19 4 AS $5.37 $120,412 D/D (22,423) 3,898,207 0 -
ALIM Alimera Sciences Inc 10% Owner   –       –       •   2013-06-19 4 AS $5.37 $1,310 D/D (244) 38,261 0 -
ALIM Alimera Sciences Inc 10% Owner   –       –       •   2013-06-20 4 AS $5.01 $571 D/D (114) 38,147 0 -
ALIM Alimera Sciences Inc 10% Owner   –       –       •   2013-06-20 4 AS $5.01 $52,685 D/D (10,516) 3,887,691 0 -
ALIM Alimera Sciences Inc 10% Owner   –       –       •   2014-01-15 4 AS $6.01 $6,070 D/D (1,010) 37,137 0 -
ALIM Alimera Sciences Inc 10% Owner   –       –       •   2014-01-15 4 AS $6.01 $555,594 D/D (92,445) 3,795,246 0 -
ALIM Alimera Sciences Inc 10% Owner   –       –       •   2014-01-16 4 AS $6.56 $1,340,306 D/D (204,315) 3,590,931 0 -
ALIM Alimera Sciences Inc 10% Owner   –       –       •   2014-01-16 4 AS $6.56 $14,629 D/D (2,230) 34,907 0 -
PRTK Paratek Pharmaceuticals I... 10% Owner   –       –       •   2006-05-15 4 B $6.50 $2,999,997 I/I 461,538 98,075 1.5 -
OREX Orexigen Therapeutics, In... 10% Owner   –       –       •   2007-05-01 4 B $12.00 $6,300,000 I/I 525,000 104,975 1.5 -
OREX Orexigen Therapeutics, In... 10% Owner   –       –       •   2008-12-08 4 B $4.47 $1,110,397 I/I 248,411 4,173 1.5 -
OREX Orexigen Therapeutics, In... 10% Owner   –       –       •   2008-12-09 4 B $4.93 $1,192,518 I/I 241,890 8,237 1.5 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2009-02-18 4 B $7.13 $19,826,206 I/I 2,780,674 46,634 1.5 -
OREX Orexigen Therapeutics, In... 10% Owner   –       –       •   2009-07-23 4 B $7.50 $4,875,000 I/I 650,000 19,138 1.5 -
OREX Orexigen Therapeutics, In... 10% Owner   –       –       •   2009-08-11 4 B $7.60 $792,680 I/I 104,300 20,887 1.5 -
OREX Orexigen Therapeutics, In... 10% Owner   –       –       •   2009-08-12 4 B $8.00 $3,200,000 I/I 400,000 27,595 1.5 -
OREX Orexigen Therapeutics, In... 10% Owner   –       –       •   2009-08-13 4 B $7.85 $102,050 I/I 13,000 27,813 1.5 -
OREX Orexigen Therapeutics, In... 10% Owner   –       –       •   2009-08-14 4 B $8.00 $209,800 I/I 26,225 28,253 1.5 -
  282  Records found
  1   2   3   4   5   6   7   8  9   10   11   12      
  Page 8 of 12  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us